NanoViricides, Inc. (NNVC)
AMEX · Common · CUSIP 630087203
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NNVC and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
630087203
Market Cap
Micro Cap
IPO
9/25/2013 · $3.50/unit
Previous Symbol
NNVCD (changed 9/25/2013)
Business: NanoViricides, Inc.is a development-stage company. The Company is a nano-biopharmaceutical (nanomedicine) company whose business goals are to discover, develop and commercialize therapeutics to advance the care of patients suffering from life-threatening viral infections. The Company has several drugs in various stages of early development. The Company’s drugs are based on several patents, patent applications, provisional patent applications, and other property held by TheraCour Pharma, Inc., to which the Company has exclusive licenses in perpetuity for the treatment of several human viral diseases.

Company Contact

CHR
Anil R. Diwan
CFO
Meeta R. Vyas
Headquarters
1 Controls Drive, Shelton, CT 06484
Phone
203-937-6137
Fax
203-859-5095
Investor Relations
Anil R. Diwan · 203-937-6137 · investors@nanoviricides.com
General Email
info@nanoviricides.com
SEC EDGAR Filings
View filings »